Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+ -ATPase inhibition.

Silva IT, Munkert J, Nolte E, Schneider NFZ, Rocha SC, Ramos ACP, Kreis W, Braga FC, De Padua RM, Taranto AG, Cortes VF, Barbosa LA, Wach S, Taubert H, Simões CMO (2018)

Publication Language: English

Publication Status: Published

Publication Type: Journal article, Original article

Publication year: 2018

Journal

Biomedicine & Pharmacotherapy Elsevier Masson

Book Volume: 107

Pages Range: 464-474

DOI: 10.1016/j.biopha.2018.08.028

Abstract


Authors with CRIS profile

Jennifer Munkert Lehrstuhl für Pharmazeutische Biologie Elke Nolte Professur für Genetik Wolfgang Kreis Lehrstuhl für Pharmazeutische Biologie Helge Taubert Professur für Molekulare Urologie

Involved external institutions

Universidade Federal de Minas Gerais (UFMG) BR Brazil (BR)

How to cite

APA:

Silva, I.T., Munkert, J., Nolte, E., Schneider, N.F.Z., Rocha, S.C., Ramos, A.C.P.,... Simões, C.M.O. (2018). Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+ -ATPase inhibition. Biomedicine & Pharmacotherapy, 107, 464-474. https://doi.org/10.1016/j.biopha.2018.08.028

MLA:

Silva, Izabella Thais, et al. "Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+ -ATPase inhibition." Biomedicine & Pharmacotherapy 107 (2018): 464-474.

BibTeX: Download